webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

DAPOA (DCHA)

  CAS No.:   Cat No.: BADC-01902 4.5  

DAPOA (DCHA) is a cleavable ADC linker intermediate designed for efficient conjugation and controlled drug release in antibody-drug conjugates. It improves stability and therapeutic index in targeted cancer therapies. Keywords: ADC linker, cleavable linker, drug conjugation, controlled release, antibody-drug conjugates.

DAPOA (DCHA)

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C17H31N7O3
Molecular Weight
381.47

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products

DAPOA (DCHA) is a versatile chemical compound with wide-ranging applications in biosciences and industry. Here are some key applications of DAPOA (DCHA)

Pharmaceutical Intermediate: DAPOA (DCHA) is extensively used as an intermediate in the synthesis of various pharmaceutical compounds. Its unique chemical structure allows for the creation of complex molecules that are crucial for drug development. By serving as a building block, DAPOA (DCHA) supports the production of medications for a range of therapeutic areas, including cardiovascular diseases and neurological disorders.

Polymer and Material Science: In the field of polymer and material science, DAPOA (DCHA) is utilized to produce high-performance polymers and resins. These materials are essential in creating durable and lightweight components for automotive, aerospace, and consumer electronics industries. Its incorporation improves the mechanical properties, thermal stability, and chemical resistance of the final products.

Catalysis: DAPOA (DCHA) is used as a ligand in catalytic processes, facilitating the creation of efficient and selective catalysts for chemical reactions. These catalysts are pivotal in industrial processes such as hydrogenation, hydroformylation, and polymerization. By enhancing catalyst performance, DAPOA (DCHA) contributes to more sustainable and cost-effective chemical manufacturing.

Biotechnological Research: In biotechnology, DAPOA (DCHA) serves as a key reagent in various biochemical assays and research applications. Its role in modifying proteins, nucleic acids, and other biomolecules is invaluable for studying cellular processes and molecular interactions. Researchers utilize DAPOA (DCHA) to explore novel biochemical pathways, protein engineering, and diagnostic tool development.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: SC-VC-PAB-MMAE | DBCO-PEG4-HyNic | N-Bromoacetyl-β-alanine | mPEG5-acetic acid | DAPOA (DCHA)
Send Inquiry
Verification code
Inquiry Basket